Skip to content

Public FDA record

Z-1258-2022: t:slim X2 Insulin Pump with Dexcom G5 Mobile CGM, and t:slim X2 Insulin Pump with Basal-IQ Technology

Recall record Z-1258-2022 for Tandem Diabetes Care Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1258-2022
Company in FDA record
Tandem Diabetes Care Inc
FDA classification date
Jun 10, 2022
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Insulin pumps may display unexpected fluctuation of the remaining battery life so ensure pump battery life does not fall below 25% remaining power. If the battery life drops to less than 5%, insulin delivery will continue for 30 minutes and then the pump will power off and insulin delivery will stop. If the battery reaches 1%, then insulin delivery will stop, which could lead to hyperglycemia.

Source facts

Action
On 09/10/2020, correction notices were sent to customers who were asked to acknowledge Low Power Alerts and Low Power Alarms by tapping "OK" and then charging the pump. Further, take the following precautions to ensure that your pump is properly charged, and the pump's battery life does not fall below 25% remaining power: - Periodically check the battery level indicator of your pump - Charge the pump for a short period of time every day (10 to 15 minutes) - Avoid full battery discharges A software update is planned by the end of 2020 that resolves the potential fluctuating battery life display. We will reach out to you to complete the free remote update of your insulin pump when the software update becomes available. Complete a online form to confirm that you have received this important user communication. Customers with questions were encouraged to contact diabetes@amsl.com.au In November 2020 software version 6.4.1 was released for all affected insulin pumps except Dexcom G5 Mobile CGM system pumps. On 12/06/2020, Dexcom G5 Mobile CGM system customers were informed that a new software update was available to address the battery issues but that the update requires using the Dexcom G6 CGM system. On 5/24/22, correction notices were sent to customers in Australia to update to the latest software. t:slim X2 insulin pump with Basal-IQ technology version 6.6 and Control-IQ technology version 7.6 are available with the latest software versions. Software update contact: AMSL: diabetes@amsl.com.au or 1300 851 056.
Initiated
2020-09-10
Root cause
Software design
Distribution
International distribution in the country of Australia.
Recall number
Z-1258-2022
Recall status
Open, Classified
CDRH record ID
193503
FDA classified
2022-06-10
Recall event number
90113

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗